Retatrutide
Price range: $75.00 through $325.00
Retatrutide is an investigational triple receptor agonist studied for its activity at GIP, GLP-1, and glucagon receptors, making it a compound of interest in metabolic and endocrine research.
Certificate of Analysis
Important Notice
Research Use Only. Not for human or animal consumption.
These products are intended exclusively for laboratory and scientific research by qualified professionals. They are not intended for human or veterinary use and are not approved to diagnose, treat, cure, or prevent any disease.
Description
Retatrutide is an investigational peptide compound studied as a triple hormone receptor agonist targeting the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. Its multi-receptor activity makes it a significant subject of research in metabolic signaling, energy regulation, glucose homeostasis, and endocrine pathways.
Laboratory and clinical research involving retatrutide has focused on understanding how coordinated activation of these three receptor pathways may influence complex metabolic processes. Its triple-agonist profile distinguishes it from compounds that target only one or two related receptor systems, providing researchers with a compound for investigating multi-pathway signaling interactions.
Retatrutide remains an investigational compound, and research into its safety, efficacy, and broader biological effects is ongoing.
